By Özge Özkaya
It is not clear whether long-term treatment with dienogest before in vitro fertilization (IVF) affects pregnancy and live birth rates in women with endometriosis, according to a new study published in the Journal of Obstetrics and Gynaecology Canada.
“Given limited…
Key Points
Lay Summary
By Özge Özkaya
Treatment with an extended regimen of ethinylestradiol and drospirenone improves health-related quality of life, according to a new study conducted on Japanese women with painful periods or pelvic pain due to endometriosis. (Ethinylestradiol and drospirenone are medications that are widely…
Key Points
Lay Summary
By Eylül GÜN
Even though the incidence of endometriosis is relatively high and numerous studies are being conducted to elucidate its pathogenesis, it is still a highly underdiagnosed and undertreated disease.
The symptoms of the disease are well-known; however, the correlation between the…
Key Points
Lay Summary
By Özge Özkaya
There is no difference between the oral progestin dienogest and combined oral contraceptive pills in managing pain and increasing quality of life in women with endometriosis, according to the results of a randomized, double-blind, placebo-controlled clinical trial. However, there was…
Key Points
Lay Summary
By Nasuhi Engin Aydin
Dr. Wanwisa Waiyaput and associates from Mahidol University, Bangkok, Thailand, have published their results on the immune regulatory cells of the surgically resected endometriotic cyst walls in the “Journal of Ovarian Research”.
The defective immune response is believed to have…
Key Points
Lay Summary
By Bahar Yuksel
Although the pathophysiology of endometriosis is poorly understood, endocrine drugs are widely used for reducing inflammation and patients’ symptoms.
Burla and colleagues aimed to evaluate the patients’ thoughts and expectations about the endocrine drugs which are used in the treatment…
Key Points
Lay Summary